![Peter Ulrichts](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 2 M $ al 30/06/2026
Peter Ulrichts currently works at argenx SE, as Chief Scientific Officer from 2023.
Dr. Ulrichts also formerly worked at Fédération catholique romaine neuchâteloise, as Principal.
Dr. Ulrichts received his graduate degree and doctorate degree from Ghent University and undergraduate degree from Katholieke Universiteit Leuven.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ARGENX SE 0 % | 19/02/2026 | 2.545 ( 0 % ) | 2 M $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ARGENX SE | Director Técnico/Científico/I+D | 01/01/2023 |
| Empresas | Cargo | Fin |
|---|---|---|
Fédération catholique romaine neuchâteloise | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Ghent University
 Ghent University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Katholieke Universiteit Leuven
 Katholieke Universiteit Leuven Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
argenx SE
 argenx SE BiotechnologyHealth Technology Develops therapies and medicines for the treatment of autoimmune diseases | Health Technology |
Fédération catholique romaine neuchâteloise |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
Elige MarketScreener 
